How This Miracle Drug Disappeared Over Night
Quick Overview
The HIV drug Ritonavir, marketed as Norvir, experienced a sudden and catastrophic manufacturing failure in 1998 when its semi-solid capsule formulation unexpectedly transformed into a more stable, less soluble crystal form known as Form II. This 'disappearing polymorph' phenomenon rendered the drug ineffective because it could no longer dissolve properly in the human body. Abbott Laboratories was forced to halt production and recall the medication, eventually transitioning back to an older, less palatable liquid formulation as a safety net until they could stabilize the production process.
Key Points: Ritonavir capsules underwent an spontaneous and unexpected phase transformation into a more stable, less soluble crystal form called Form II. Form II crystals failed to dissolve in the human body, rendering the drug ineffective for patients. Abbott Laboratories discovered the manufacturing failure after capsules turned cloudy and developed millions of microscopic, needle-like crystals. The company halted all production of the capsule form and launched a massive investigation, eventually re-seeding their manufacturing environment with Form II to resolve the stability issue. Abbott Laboratories transitioned patients back to the original, less palatable liquid formulation of Ritonavir during the crisis. This event serves as a critical case study in pharmaceutical manufacturing, demonstrating how 'disappearing polymorphs' can emerge unpredictably and jeopardize drug supply chains.
Context: In the mid-1990s, Ritonavir (Norvir) emerged as a breakthrough protease inhibitor for treating HIV, significantly improving patient survival rates. Its rapid approval and widespread adoption made it a critical medication for tens of thousands of patients. However, the drug's manufacturing process relied on a complex chemical structure that was vulnerable to polymorphic instability—the ability of a substance to exist in multiple crystalline forms—which triggered an unprecedented crisis in 1998.